PEX26-C22ORF28 Fusion FISH Probe
The PEX26-C22ORF28 Fusion FISH Probe is used to confirm a fusion of the PEX26 and C22ORF28 genes. The fusion of the PEX26 and C22ORF28 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PEX26-C22ORF28-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PEX26-C22ORF28-20-AQAQ | 20 (40 μL) | 200 μL |
|
PEX26 Gene Summary
This gene belongs to the peroxin-26 gene family. It is probably required for protein import into peroxisomes. It anchors PEX1 and PEX6 to peroxisome membranes, possibly to form heteromeric AAA ATPase complexes required for the import of proteins into peroxisomes. Defects in this gene are the cause of peroxisome biogenesis disorder complementation group 8 (PBD-CG8). PBD refers to a group of peroxisomal disorders arising from a failure of protein import into the peroxisomal membrane or matrix. The PBD group is comprised of four disorders: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Dec 2010]
Gene Name: Peroxisomal Biogenesis Factor 26
Chromosome: CHR22: 18560685 -18573797
Locus: 22q11.21
Gene Diseases
The PEX26 C22ORF28 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|